APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaginal Fungi Infections Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Vaginal Fungi Infections Treatment Industry Research Report 2026

19 December 2025124 pages

Choose your research edition.

Industry ResearchVaginal Fungi Infections Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaginal Fungi Infections Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Vaginal Fungi Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaginal Fungi Infections Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaginal Fungi Infections Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Vaginal Fungi Infections Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Vaginal Fungi Infections Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Vaginal Fungi Infections Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Vaginal Fungi Infections Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Vaginal Fungi Infections Treatment include ANI Pharmaceuticals, Aurobindo Pharma Limited, Bausch Health Companies Inc, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals Limited, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals and PEPTONIC medical AB, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Vaginal Fungi Infections Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Vaginal Fungi Infections Treatment.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Vaginal Fungi Infections Treatment Market by Company

ANI Pharmaceuticals

Aurobindo Pharma Limited

Bausch Health Companies Inc

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals Limited

Hikma Pharmaceuticals Plc

Lupin Limited

Mycovia Pharmaceuticals

PEPTONIC medical AB

SCYNEXIS

Unique Pharmaceuticals

Pfizer Inc.

Vaginal Fungi Infections Treatment Segment by Type

Flucytosine

Fluconazole

Nystatin

Others

Vaginal Fungi Infections Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Vaginal Fungi Infections Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaginal Fungi Infections Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaginal Fungi Infections Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaginal Fungi Infections Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Vaginal Fungi Infections Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Vaginal Fungi Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2021-2026) Table 7. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Vaginal Fungi Infections Treatment Revenue Market Share by Type (2027-2032) Table 9. Global Vaginal Fungi Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2021-2026) Table 11. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Vaginal Fungi Infections Treatment Revenue Market Share by Application (2027-2032) Table 13. Global Vaginal Fungi Infections Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Vaginal Fungi Infections Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Vaginal Fungi Infections Treatment Market Share by Region (2021-2026) Table 16. Global Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Vaginal Fungi Infections Treatment Market Share by Region (2027-2032) Table 18. Vaginal Fungi Infections Treatment Industry Trends Table 19. Vaginal Fungi Infections Treatment Industry Drivers Table 20. Vaginal Fungi Infections Treatment Industry Opportunities and Challenges Table 21. Vaginal Fungi Infections Treatment Market Restraints Table 22. Global Top Vaginal Fungi Infections Treatment Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Vaginal Fungi Infections Treatment Revenue Market Share by Players (2021-2026) Table 24. Global Vaginal Fungi Infections Treatment Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Vaginal Fungi Infections Treatment, Headquarters and Area Served Table 26. Global Vaginal Fungi Infections Treatment Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Vaginal Fungi Infections Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Vaginal Fungi Infections Treatment Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2027-2032) & (US$ Million) Table 45. ANI Pharmaceuticals Company Information Table 46. ANI Pharmaceuticals Business Overview Table 47. ANI Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 48. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 49. ANI Pharmaceuticals Recent Developments Table 50. Aurobindo Pharma Limited Company Information Table 51. Aurobindo Pharma Limited Business Overview Table 52. Aurobindo Pharma Limited Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 53. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Portfolio Table 54. Aurobindo Pharma Limited Recent Developments Table 55. Bausch Health Companies Inc Company Information Table 56. Bausch Health Companies Inc Business Overview Table 57. Bausch Health Companies Inc Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 58. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Portfolio Table 59. Bausch Health Companies Inc Recent Developments Table 60. Dr. Reddy's Laboratories Company Information Table 61. Dr. Reddy's Laboratories Business Overview Table 62. Dr. Reddy's Laboratories Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 63. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Portfolio Table 64. Dr. Reddy's Laboratories Recent Developments Table 65. Glenmark Pharmaceuticals Limited Company Information Table 66. Glenmark Pharmaceuticals Limited Business Overview Table 67. Glenmark Pharmaceuticals Limited Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 68. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Portfolio Table 69. Glenmark Pharmaceuticals Limited Recent Developments Table 70. Hikma Pharmaceuticals Plc Company Information Table 71. Hikma Pharmaceuticals Plc Business Overview Table 72. Hikma Pharmaceuticals Plc Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 73. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Portfolio Table 74. Hikma Pharmaceuticals Plc Recent Developments Table 75. Lupin Limited Company Information Table 76. Lupin Limited Business Overview Table 77. Lupin Limited Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 78. Lupin Limited Vaginal Fungi Infections Treatment Product Portfolio Table 79. Lupin Limited Recent Developments Table 80. Mycovia Pharmaceuticals Company Information Table 81. Mycovia Pharmaceuticals Business Overview Table 82. Mycovia Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 83. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 84. Mycovia Pharmaceuticals Recent Developments Table 85. PEPTONIC medical AB Company Information Table 86. PEPTONIC medical AB Business Overview Table 87. PEPTONIC medical AB Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 88. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Portfolio Table 89. PEPTONIC medical AB Recent Developments Table 90. SCYNEXIS Company Information Table 91. SCYNEXIS Business Overview Table 92. SCYNEXIS Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 93. SCYNEXIS Vaginal Fungi Infections Treatment Product Portfolio Table 94. SCYNEXIS Recent Developments Table 95. Unique Pharmaceuticals Company Information Table 96. Unique Pharmaceuticals Business Overview Table 97. Unique Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 98. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio Table 99. Unique Pharmaceuticals Recent Developments Table 100. Pfizer Inc. Company Information Table 101. Pfizer Inc. Business Overview Table 102. Pfizer Inc. Revenue in Vaginal Fungi Infections Treatment Business (2021-2026) & (US$ Million) Table 103. Pfizer Inc. Vaginal Fungi Infections Treatment Product Portfolio Table 104. Pfizer Inc. Recent Developments Table 105. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Vaginal Fungi Infections Treatment Product Image Figure 5. Global Vaginal Fungi Infections Treatment Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Vaginal Fungi Infections Treatment Market Share by Type: 2025 VS 2032 Figure 7. Flucytosine Product Figure 8. Fluconazole Product Figure 9. Nystatin Product Figure 10. Others Product Figure 11. Global Vaginal Fungi Infections Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Vaginal Fungi Infections Treatment Market Share by Application: 2025 VS 2032 Figure 13. Hospital Pharmacies Product Figure 14. Online Pharmacies Product Figure 15. Retail Pharmacies Product Figure 16. Global Vaginal Fungi Infections Treatment Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Vaginal Fungi Infections Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Vaginal Fungi Infections Treatment Market Share by Region: 2025 VS 2032 Figure 19. Global Vaginal Fungi Infections Treatment Market Share by Players in 2025 Figure 20. Global Vaginal Fungi Infections Treatment Manufacturers Established Date Figure 21. Global Top 5 and 10 Vaginal Fungi Infections Treatment Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 25. United States Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 28. Europe Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 30. Germany Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 40. China Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 45. Australia Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Vaginal Fungi Infections Treatment Market Share by Country (2021-2032) Figure 50. Brazil Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Vaginal Fungi Infections Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. ANI Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 56. Aurobindo Pharma Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 57. Bausch Health Companies Inc Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 59. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 60. Hikma Pharmaceuticals Plc Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 61. Lupin Limited Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 62. Mycovia Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 63. PEPTONIC medical AB Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 64. SCYNEXIS Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 65. Unique Pharmaceuticals Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026) Figure 66. Pfizer Inc. Revenue Growth Rate in Vaginal Fungi Infections Treatment Business (2021-2026)

Scope & coverage.

Types
  • Flucytosine
  • Fluconazole
  • Nystatin
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • ANI Pharmaceuticals
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc
  • Dr. Reddy's Laboratories
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals Plc
  • Lupin Limited
  • Mycovia Pharmaceuticals
  • PEPTONIC medical AB
  • SCYNEXIS
  • Unique Pharmaceuticals
  • Pfizer Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Vaginal Fungi Infections Treatment by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Flucytosine
  5. 2.2.3 Fluconazole
  6. 2.2.4 Nystatin
  7. 2.2.5 Others
  8. 2.3 Vaginal Fungi Infections Treatment by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Hospital Pharmacies
  11. 2.3.3 Online Pharmacies
  12. 2.3.4 Retail Pharmacies
  13. 2.4 Assumptions and Limitations
3 Vaginal Fungi Infections Treatment Breakdown Data by Type
  1. 3.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Type (2021-2026)
  2. 3.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Type (2027-2032)
4 Vaginal Fungi Infections Treatment Breakdown Data by Application
  1. 4.1 Global Vaginal Fungi Infections Treatment Historic Market Size by Application (2021-2026)
  2. 4.2 Global Vaginal Fungi Infections Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Vaginal Fungi Infections Treatment Market Perspective (2021-2032)
  2. 5.2 Global Vaginal Fungi Infections Treatment Growth Trends by Region
  3. 5.2.1 Global Vaginal Fungi Infections Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Vaginal Fungi Infections Treatment Historic Market Size by Region (2021-2026)
  5. 5.2.3 Vaginal Fungi Infections Treatment Forecasted Market Size by Region (2027-2032)
  6. 5.3 Vaginal Fungi Infections Treatment Market Dynamics
  7. 5.3.1 Vaginal Fungi Infections Treatment Industry Trends
  8. 5.3.2 Vaginal Fungi Infections Treatment Market Drivers
  9. 5.3.3 Vaginal Fungi Infections Treatment Market Challenges
  10. 5.3.4 Vaginal Fungi Infections Treatment Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Vaginal Fungi Infections Treatment Players by Revenue
  2. 6.1.1 Global Top Vaginal Fungi Infections Treatment Players by Revenue (2021-2026)
  3. 6.1.2 Global Vaginal Fungi Infections Treatment Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Vaginal Fungi Infections Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Vaginal Fungi Infections Treatment Head Office and Area Served
  6. 6.4 Global Vaginal Fungi Infections Treatment Players, Product Type & Application
  7. 6.5 Global Vaginal Fungi Infections Treatment Manufacturers Established Date
  8. 6.6 Global Vaginal Fungi Infections Treatment Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 7.2 North America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  4. 7.4 North America Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 8.2 Europe Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  4. 8.4 Europe Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 9.2 Asia-Pacific Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 10.2 South America Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  4. 10.4 South America Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Vaginal Fungi Infections Treatment Market Size (2021-2032)
  2. 11.2 Middle East & Africa Vaginal Fungi Infections Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Vaginal Fungi Infections Treatment Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 ANI Pharmaceuticals
  2. 12.1.1 ANI Pharmaceuticals Company Information
  3. 12.1.2 ANI Pharmaceuticals Business Overview
  4. 12.1.3 ANI Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  5. 12.1.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  6. 12.1.5 ANI Pharmaceuticals Recent Developments
  7. 12.2 Aurobindo Pharma Limited
  8. 12.2.1 Aurobindo Pharma Limited Company Information
  9. 12.2.2 Aurobindo Pharma Limited Business Overview
  10. 12.2.3 Aurobindo Pharma Limited Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  11. 12.2.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product Portfolio
  12. 12.2.5 Aurobindo Pharma Limited Recent Developments
  13. 12.3 Bausch Health Companies Inc
  14. 12.3.1 Bausch Health Companies Inc Company Information
  15. 12.3.2 Bausch Health Companies Inc Business Overview
  16. 12.3.3 Bausch Health Companies Inc Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  17. 12.3.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product Portfolio
  18. 12.3.5 Bausch Health Companies Inc Recent Developments
  19. 12.4 Dr. Reddy's Laboratories
  20. 12.4.1 Dr. Reddy's Laboratories Company Information
  21. 12.4.2 Dr. Reddy's Laboratories Business Overview
  22. 12.4.3 Dr. Reddy's Laboratories Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  23. 12.4.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product Portfolio
  24. 12.4.5 Dr. Reddy's Laboratories Recent Developments
  25. 12.5 Glenmark Pharmaceuticals Limited
  26. 12.5.1 Glenmark Pharmaceuticals Limited Company Information
  27. 12.5.2 Glenmark Pharmaceuticals Limited Business Overview
  28. 12.5.3 Glenmark Pharmaceuticals Limited Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  29. 12.5.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product Portfolio
  30. 12.5.5 Glenmark Pharmaceuticals Limited Recent Developments
  31. 12.6 Hikma Pharmaceuticals Plc
  32. 12.6.1 Hikma Pharmaceuticals Plc Company Information
  33. 12.6.2 Hikma Pharmaceuticals Plc Business Overview
  34. 12.6.3 Hikma Pharmaceuticals Plc Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  35. 12.6.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product Portfolio
  36. 12.6.5 Hikma Pharmaceuticals Plc Recent Developments
  37. 12.7 Lupin Limited
  38. 12.7.1 Lupin Limited Company Information
  39. 12.7.2 Lupin Limited Business Overview
  40. 12.7.3 Lupin Limited Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  41. 12.7.4 Lupin Limited Vaginal Fungi Infections Treatment Product Portfolio
  42. 12.7.5 Lupin Limited Recent Developments
  43. 12.8 Mycovia Pharmaceuticals
  44. 12.8.1 Mycovia Pharmaceuticals Company Information
  45. 12.8.2 Mycovia Pharmaceuticals Business Overview
  46. 12.8.3 Mycovia Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  47. 12.8.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  48. 12.8.5 Mycovia Pharmaceuticals Recent Developments
  49. 12.9 PEPTONIC medical AB
  50. 12.9.1 PEPTONIC medical AB Company Information
  51. 12.9.2 PEPTONIC medical AB Business Overview
  52. 12.9.3 PEPTONIC medical AB Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  53. 12.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product Portfolio
  54. 12.9.5 PEPTONIC medical AB Recent Developments
  55. 12.10 SCYNEXIS
  56. 12.10.1 SCYNEXIS Company Information
  57. 12.10.2 SCYNEXIS Business Overview
  58. 12.10.3 SCYNEXIS Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  59. 12.10.4 SCYNEXIS Vaginal Fungi Infections Treatment Product Portfolio
  60. 12.10.5 SCYNEXIS Recent Developments
  61. 12.11 Unique Pharmaceuticals
  62. 12.11.1 Unique Pharmaceuticals Company Information
  63. 12.11.2 Unique Pharmaceuticals Business Overview
  64. 12.11.3 Unique Pharmaceuticals Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  65. 12.11.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product Portfolio
  66. 12.11.5 Unique Pharmaceuticals Recent Developments
  67. 12.12 Pfizer Inc.
  68. 12.12.1 Pfizer Inc. Company Information
  69. 12.12.2 Pfizer Inc. Business Overview
  70. 12.12.3 Pfizer Inc. Revenue in Vaginal Fungi Infections Treatment Business (2021-2026)
  71. 12.12.4 Pfizer Inc. Vaginal Fungi Infections Treatment Product Portfolio
  72. 12.12.5 Pfizer Inc. Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst